Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.78 USD | +0.21% | -22.90% | -60.41% |
Business Summary
Number of employees: 3
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 22-07-31 | |
David Jin
DFI | Director of Finance/CFO | 34 | - |
Michael Ryan
CTO | Chief Tech/Sci/R&D Officer | - | 18-08-31 |
Scott A. Reines
CTO | Chief Tech/Sci/R&D Officer | 77 | 15-12-31 |
Jaclyn Jaffe
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 68 | 15-02-08 | |
Jay Kranzler
CHM | Chairman | 66 | 17-01-31 |
Neil Herskowitz
BRD | Director/Board Member | 67 | 15-07-31 |
Faith Charles
BRD | Director/Board Member | 62 | 22-05-15 |
Curtis Oltmans
BRD | Director/Board Member | 60 | 21-03-31 |
Chief Executive Officer | 57 | 22-07-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 590,143 | 520,427 ( 88.19 %) | 0 | 88.19 % |
Stock B | 0 | 250,000 | 0 | 0 |
Company contact information
Avenue Therapeutics, Inc.
1111 Kane Concourse Suite 301
33154, Bay Harbor Islands
+781 652 4500
http://www.avenuetx.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.41% | 2.82M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- ATXI Stock
- Company Avenue Therapeutics, Inc.